Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

The Intermediate Dose Verse Conventional Dose Cytarabine in Induction Therapy in Adult Acute Myeloid Leukemia: A Phase Ⅲ Randomized Controlled Trial

Hui Wei, MD, Ying Wang, MD, Dong Lin, MD, Chunlin Zhou, Bingcheng Liu, MD, Shaowei Qiu, MD, Benfa Gong, Kaiqi Liu, Guangji Zhang, Shuning Wei, Xiaoyuan Gong, Yuntao Liu, Yan Li, MD, Yingchang Mi, MD, Jianxiang Wang, MD

Blood (2017) 130 (Supplement 1): 146.

https://doi.org/10.1182/blood.V130.Suppl_1.146.146

Published: 2017

Journal Articles

The Impact of Allogeneic Hematopoietic Stem-Cell Transplantation on Outcome of the Patients with Intermediate-Risk Acute Myeloid Leukemia

Ying Wang, MD, Hui Wei, MD PhD, Dong Lin, MD PhD, Chunlin Zhou, MD PhD, Bingcheng Liu, Shaowei Qiu, Benfa Gong, Guangji Zhang, Kaiqi Liu, Shuning Wei, Yuntao Liu, Xiaoyuan Gong, MD, Xingli Zhao, Yan Li, MD, Runxia Gu, MD PhD, Yingchang Mi, MD, PhD, Jianxiang Wang, MD

Blood (2016) 128 (22): 4015.

https://doi.org/10.1182/blood.V128.22.4015.4015

Published: 2016

Journal Articles

MRD Is an Independent Prognostic Factor in Acute Myeloid Leukemia Carrying t(8;21) Chromosomal Abnormalities

Hui Wei, MD PhD, Ying Wang, MD, Dong Lin, MD PhD, Chunlin Zhou, MD PhD, Bingcheng Liu, Shaowei Qiu, Benfa Gong, Guangji Zhang, Kaiqi Liu, Shuning Wei, Xiaoyuan Gong, MD, Yuntao Liu, Yan Li, MD, Runxia Gu, MD PhD, Yingchang Mi, MD PhD, Jianxiang Wang, MD

Blood (2016) 128 (22): 1672.

https://doi.org/10.1182/blood.V128.22.1672.1672

Published: 2016

Journal Articles

Impact of Additional Chromosomal Abnormalities in Philadelphia-Positive Clone on Prognosis of CML Patients Treated with Tyrosine Kinase Inhibitors

Bingcheng Liu, Ying Wang, MD, Hui Wei, MD PhD, Kaiqi Liu, Dong Lin, MD PhD, Chunlin Zhou, MD PhD, Yingchang Mi, MD, PhD, Jianxiang Wang, MD

Blood (2016) 128 (22): 1926.

https://doi.org/10.1182/blood.V128.22.1926.1926

Published: 2016

Journal Articles

Clinical Characteristics and Factors of the Impact on the Survival in 133 De Novo FLT3-ITD Acute Myeloid Leukemia with Intermediate Chromosome Karyoptye from a Single Center of China

Shaowei Qiu, MD, Dong Lin, MD PhD, Hui Wei, MD PhD, Guangji Zhang, Chunlin Zhou, MD PhD, Kaiqi Liu, Shuning Wei, Ying Wang, MD, Bingcheng Liu, Benfa Gong, Xiaoyuan Gong, MD, Yuntao Liu, Yingchang Mi, MD PhD, Jianxiang Wang, MD

Blood (2016) 128 (22): 5240.

https://doi.org/10.1182/blood.V128.22.5240.5240

Published: 2016

Journal Articles

Clinical Significance of Myeloblasts Percentage in the De Novo Acute Myeloid Leukemia with Erythroid Hyperplasia

Shaowei Qiu, MD, Hui Wei, MD PhD, Dong Lin, MD PhD, Guangji Zhang, Shuning Wei, Chunlin Zhou, MD PhD, Kaiqi Liu, Ying Wang, MD, Bingcheng Liu, Yuntao Liu, Benfa Gong, Xiaoyuan Gong, MD, Sizhou Feng, Yingchang Mi, MD PhD, Mingzhe Han, Jianxiang Wang, MD

Blood (2016) 128 (22): 5245.

https://doi.org/10.1182/blood.V128.22.5245.5245

Published: 2016

Journal Articles

Application of Homoharringtonine in the Treatment of Acute Promyelocytic Leukemia.

Jianxiang Wang, MD, Yingchang Mi, MD, PhD, Mingwei Fu, MD, Tiejun Qin, MD, Dong Lin, MD, PhD, Jie Bai, MD, PhD, Liping Jing, MD, Dapeng Li, MD, Xiujuan Sun, MD, Shougeng Bian, MD

Blood (2007) 110 (11): 1841.

https://doi.org/10.1182/blood.V110.11.1841.1841

Published: 2007

NARROW

The Intermediate Dose Verse Conventional Dose Cytarabine in Induction Therapy in Adult Acute Myeloid Leukemia: A Phase Ⅲ Randomized Controlled Trial

The Impact of Allogeneic Hematopoietic Stem-Cell Transplantation on Outcome of the Patients with Intermediate-Risk Acute Myeloid Leukemia

MRD Is an Independent Prognostic Factor in Acute Myeloid Leukemia Carrying t(8;21) Chromosomal Abnormalities

Impact of Additional Chromosomal Abnormalities in Philadelphia-Positive Clone on Prognosis of CML Patients Treated with Tyrosine Kinase Inhibitors

Clinical Characteristics and Factors of the Impact on the Survival in 133 De Novo FLT3-ITD Acute Myeloid Leukemia with Intermediate Chromosome Karyoptye from a Single Center of China

Clinical Significance of Myeloblasts Percentage in the De Novo Acute Myeloid Leukemia with Erythroid Hyperplasia

Application of Homoharringtonine in the Treatment of Acute Promyelocytic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

The Intermediate Dose Verse Conventional Dose Cytarabine in Induction Therapy in Adult Acute Myeloid Leukemia: A Phase Ⅲ Randomized Controlled Trial

The Impact of Allogeneic Hematopoietic Stem-Cell Transplantation on Outcome of the Patients with Intermediate-Risk Acute Myeloid Leukemia

MRD Is an Independent Prognostic Factor in Acute Myeloid Leukemia Carrying t(8;21) Chromosomal Abnormalities

Impact of Additional Chromosomal Abnormalities in Philadelphia-Positive Clone on Prognosis of CML Patients Treated with Tyrosine Kinase Inhibitors

Clinical Characteristics and Factors of the Impact on the Survival in 133 De Novo FLT3-ITD Acute Myeloid Leukemia with Intermediate Chromosome Karyoptye from a Single Center of China

Clinical Significance of Myeloblasts Percentage in the De Novo Acute Myeloid Leukemia with Erythroid Hyperplasia

Application of Homoharringtonine in the Treatment of Acute Promyelocytic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only